Bayer and Onyx Initiate Phase III Trial of Nexavar® in Patients with Non-Responsive Thyroid Cancer
- Details
- Category: Bayer

Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer
- Details
- Category: Bayer

Bristol-Myers Squibb Achieves Strong Sales
- Details
- Category: Bristol-Myers Squibb

The 4-T study of intensified insulin regimens shows excellent three-year glucose control
- Details
- Category: Novo Nordisk

Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent
- Details
- Category: Amgen

Pfizer Reports Third-Quarter 2009 Results
- Details
- Category: Pfizer

Novartis drug Tasigna® meets primary endpoint in pivotal trial against Glivec®
- Details
- Category: Novartis

- First registration study using molecular response as key indicator of patient outcomes; Bcr-Abl biomarker test measures very low levels of residual disease[1],[2]
More Pharma News ...
- Abbott Completes Visiogen Acquisition
- FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
- FDA approves Micardis® (telmisartan) as the first treatment in its class
- FDA Approves CRESTOR for Use in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
- Pfizer And Wyeth Become One: Working Together For A Healthier Worldâ¢
- Pfizer Completes Acquisition Of Wyeth
- GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy